John Heymach, MD, PhD

Chair of Thoracic/Head and Neck Medical Oncology
Division of Cancer Medicine, University of Texas MD Anderson Cancer Center

Poster(s):

• (301) Zongertinib in patients with pretreated human epidermal growth factor receptor 2-mutant advanced non–small cell lung cancer: Beamion LUNG-1
  Wednesday, October 29, 2025